This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$24.3M
Filings
330
Firms Hired
6
Active Period
2007–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.
Client expense: — · Firm income: $21,000
Matched citations: H.R. 9061
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: H.R. 5269
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · third_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034). 2027 Public Law No: 119-103 - Continuing Appropriations and Extensions Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: H.R. 5304
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: H.R. 5343
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: H.R. 9061
General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities. H.R. 9438 - Supporting Knowledge through Industry-Led Learning (SKILL) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: H.R. 9438
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: S. 1717
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · third_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034). 2027 Public Law No: 119-103 - Continuing Appropriations and Extensions Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: S. 2587
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $550,000 · Firm income: —
Matched citations: S. 2761
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 5269
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · second_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034).
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 5304
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 5343
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 9061
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · second_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $280,000 · Firm income: —
Matched citations: S. 1717
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · second_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034).
Client expense: $280,000 · Firm income: —
Matched citations: S. 2587
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.
Client expense: $280,000 · Firm income: —
Matched citations: S. 2761
Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.
Client expense: — · Firm income: $21,000
Matched citations: H.R. 9061
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 5269
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · first_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds.
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 5304
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $710,000 · Firm income: —
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · first_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $710,000 · Firm income: —
Matched citations: S. 1717
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2026 · first_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds.
Client expense: $710,000 · Firm income: —
Matched citations: S. 2587
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $710,000 · Firm income: —
Matched citations: S. 2761
College for All Act of 2025
2025 · fourth_quarter · Firm: THERMO FISHER SCIENTIFIC INC.
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 3543: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $470,000 · Firm income: —
Matched citations: H.R. 3543
General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 3543: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.
Client expense: $470,000 · Firm income: —
Matched citations: H.R. 5269
Source: Senate LDA